Sponsor
Peking Union Medical College Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Peking Union Medical College Hospital appears in 260 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Randomized Controlled Trial of 3D Airway Reconstruction for Precise Double-Lumen Bronchial IntubationNCT07719959 · lead sponsor · 2026-08-14
RECRUITINGFaecal Microbiota Transplantation in Patients With Refractory Rheumatoid ArthritisNCT07639177 · lead sponsor · 2026-07-01
RECRUITINGRisk Factor Assessment for Acute Pulmonary Hypertension CrisisNCT07653958 · lead sponsor · 2026-06-17
RECRUITINGConstruction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI ModelsNCT07500428 · lead sponsor · 2026-03-12
RECRUITINGAn Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLCNCT07452003 · lead sponsor · 2026-01-03
RECRUITINGApplication of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related DiseasesNCT07464132 · lead sponsor · 2025-12-17
RECRUITINGAdjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World StudyNCT07640048 · lead sponsor · 2025-05-04
RECRUITINGThe Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)NCT06861543 · lead sponsor · 2025-03-01
RECRUITINGHypofractionated Online Adaptive Radiotherapy of Breast CancerNCT06568705 · lead sponsor · 2024-09-01
RECRUITINGLarge Segmentation Radiotherapy ± Deep Inspiration Breath Hold(DIBH) for Left Breast CancerNCT06660628 · lead sponsor · 2024-08-21
RECRUITINGICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICINCT06388031 · lead sponsor · 2024-08-09
RECRUITINGFurmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical MutationsNCT06674343 · lead sponsor · 2024-07-15
RECRUITINGAnalyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CTNCT07062523 · lead sponsor · 2024-07-01
RECRUITINGApplication of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast CancerNCT06411678 · lead sponsor · 2024-05-10
RECRUITINGSerplulimab Combined With CCRT for LS-SCLC.NCT06295926 · lead sponsor · 2024-04-04
RECRUITINGBelimumab After Rituximab in Resistant Primary Juvenile SSNCT06410833 · lead sponsor · 2024-03-09
RECRUITINGCOVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker ResearchNCT06168032 · lead sponsor · 2023-12-08
RECRUITING99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast CancerNCT06104085 · lead sponsor · 2023-09-13
RECRUITINGEffects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated PatientsNCT07065942 · lead sponsor · 2023-07-01
RECRUITINGPhotoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response EvaluationNCT06908291 · lead sponsor · 2023-06-12
RECRUITINGPyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast CancerNCT06035016 · lead sponsor · 2023-06-01
RECRUITING177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate CancerNCT05603559 · lead sponsor · 2023-01-01
RECRUITING68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor PatientsNCT05549024 · lead sponsor · 2022-08-16
RECRUITINGRisk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic DiseasesNCT05476627 · lead sponsor · 2022-07-01
RECRUITINGA Real World Study of Ensartinib in Advanced ALK-positive NSCLCNCT05498064 · lead sponsor · 2022-05-13
RECRUITINGObservational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID RegistryNCT06417502 · lead sponsor · 2022-04-29
RECRUITING68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer PatientsNCT05324332 · lead sponsor · 2022-04-15
RECRUITINGOptical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast CancerNCT05804916 · lead sponsor · 2022-04-01
RECRUITINGScreening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver DiseaseNCT05330923 · lead sponsor · 2022-01-01
RECRUITINGPhase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung CancerNCT05751018 · lead sponsor · 2021-12-08
RECRUITINGAssessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)NCT05559645 · lead sponsor · 2021-11-18
RECRUITINGPUMCH Dementia Longitudinal Cohort StudyNCT05023564 · lead sponsor · 2020-12-01
RECRUITINGGut and Vaginal Microbiota Profile Study for HIV WomenNCT05996016 · lead sponsor · 2017-01-01
RECRUITINGEarly Precise Identification and Intervention Strategies for Individuals at High Risk of PrediabetesNCT07386756 · lead sponsor · 2026-04-30
NOT_YET_RECRUITINGStudy on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 DiabetesNCT07063797 · lead sponsor · 2026-02-01
NOT_YET_RECRUITINGSafety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)NCT07381582 · lead sponsor · 2026-01-01
NOT_YET_RECRUITINGPrecision Diabetes Management: Integrated East-West ApproachNCT07307040 · lead sponsor · 2025-12-31
NOT_YET_RECRUITINGIndividualized Early Diagnosis and Treatment System of Gestational Diabetes Mellitus (GDM) Based on New Continuous Glucose Monitoring (CGM) TechnologyNCT07276945 · lead sponsor · 2025-12-10
NOT_YET_RECRUITINGHigh-throughput Large-model-based AI-assisted Diagnosis Using OCTNCT07249307 · lead sponsor · 2025-11-30
NOT_YET_RECRUITINGDigital Therapy for Individualized Intervention and Management of Gestational Diabetes MellitusNCT07173959 · lead sponsor · 2025-10-08
NOT_YET_RECRUITINGChanges in Body Composition of Patients With Obesity Related Tumors and Their Impact on Clinical Outcomes: a Multicenter Prospective Cohort StudyNCT07161167 · lead sponsor · 2025-09-15
NOT_YET_RECRUITINGProspective Observational Study on ES-SCLCNCT07173946 · lead sponsor · 2025-09-01
NOT_YET_RECRUITINGOrganoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung CancerNCT07106528 · lead sponsor · 2025-08-01
NOT_YET_RECRUITINGRationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant TherapyNCT07012707 · lead sponsor · 2025-06-01
NOT_YET_RECRUITINGStudy on the Weight Loss Effects and Mechanisms of Probiotic Preparation Intervention in Weight CyclersNCT07031596 · lead sponsor · 2025-06-01
NOT_YET_RECRUITINGBenmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung CancerNCT06931145 · lead sponsor · 2025-04-15
NOT_YET_RECRUITINGAumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung CancerNCT06752408 · lead sponsor · 2024-12-17
NOT_YET_RECRUITING⁶⁸Ga-DPA in the Lung Cancer DiagnosisNCT07023068 · lead sponsor · 2024-09-28
ENROLLING_BY_INVITATIONObservation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 GradeNCT06489158 · lead sponsor · 2024-09-09
UNKNOWNMultidisciplinary Prehabilitation Management Pathway and Network Platform ConstructionNCT06573788 · lead sponsor · 2024-09-01
UNKNOWN[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate CancerNCT06864572 · lead sponsor · 2024-09-01
ENROLLING_BY_INVITATIONEffects of Selenium Towards Type 2 DiabetesNCT06457984 · lead sponsor · 2024-06-15
UNKNOWNDeveloping a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural UltrasoundNCT06423066 · lead sponsor · 2024-06-01
UNKNOWNComparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube DrainageNCT06410716 · lead sponsor · 2024-04-20
UNKNOWNThe Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind TrialNCT06167902 · lead sponsor · 2023-12-25
UNKNOWNA Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.NCT06142617 · lead sponsor · 2023-12-01
NOT_YET_RECRUITINGApplication of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung CancerNCT06194630 · lead sponsor · 2023-11-30
UNKNOWNThe Choice of Treatment Methods and Efficacy of LABCNCT06080620 · lead sponsor · 2023-10-08
UNKNOWNThe Effects of Aronia Melanocarpa Extract on Obese Individuals With Impaired Fasting Blood GlucoseNCT06057389 · lead sponsor · 2023-10-07
UNKNOWNTo Identify Urinary Biomarkers Associated With Gestational Diabetes Mellitus [GDM]NCT05992974 · lead sponsor · 2023-08-31
UNKNOWNSponsor roles
lead sponsor216
collaborator44
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.